165 related articles for article (PubMed ID: 36302965)
1. The effect of oxytocin nasal spray on social interaction in young children with autism: a randomized clinical trial.
Guastella AJ; Boulton KA; Whitehouse AJO; Song YJ; Thapa R; Gregory SG; Pokorski I; Granich J; DeMayo MM; Ambarchi Z; Wray J; Thomas EE; Hickie IB
Mol Psychiatry; 2023 Feb; 28(2):834-842. PubMed ID: 36302965
[TBL] [Abstract][Full Text] [Related]
2. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.
Yatawara CJ; Einfeld SL; Hickie IB; Davenport TA; Guastella AJ
Mol Psychiatry; 2016 Sep; 21(9):1225-31. PubMed ID: 26503762
[TBL] [Abstract][Full Text] [Related]
3. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
[TBL] [Abstract][Full Text] [Related]
4. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
[TBL] [Abstract][Full Text] [Related]
5. Infrequent Intranasal Oxytocin Followed by Positive Social Interaction Improves Symptoms in Autistic Children: A Pilot Randomized Clinical Trial.
Le J; Zhang L; Zhao W; Zhu S; Lan C; Kou J; Zhang Q; Zhang Y; Li Q; Chen Z; Fu M; Montag C; Zhang R; Yang W; Becker B; Kendrick KM
Psychother Psychosom; 2022; 91(5):335-347. PubMed ID: 35545057
[TBL] [Abstract][Full Text] [Related]
6. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
Yamasue H; Kojima M; Kuwabara H; Kuroda M; Matsumoto K; Kanai C; Inada N; Owada K; Ochi K; Ono N; Benner S; Wakuda T; Kameno Y; Inoue J; Harada T; Tsuchiya K; Umemura K; Yamauchi A; Ogawa N; Kushima I; Ozaki N; Suyama S; Saito T; Uemura Y; Hamada J; Kano Y; Honda N; Kikuchi S; Seto M; Tomita H; Miyoshi N; Matsumoto M; Kawaguchi Y; Kanai K; Ikeda M; Nakamura I; Isomura S; Hirano Y; Onitsuka T; Kosaka H; Okada T
Brain; 2022 Apr; 145(2):490-499. PubMed ID: 35067719
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up.
Bernaerts S; Boets B; Bosmans G; Steyaert J; Alaerts K
Mol Autism; 2020; 11(1):6. PubMed ID: 31969977
[TBL] [Abstract][Full Text] [Related]
8. Can repeated intranasal oxytocin administration affect reduced neural sensitivity towards expressive faces in autism? A randomized controlled trial.
Moerkerke M; Daniels N; Van der Donck S; Tibermont L; Tang T; Debbaut E; Bamps A; Prinsen J; Steyaert J; Alaerts K; Boets B
J Child Psychol Psychiatry; 2023 Nov; 64(11):1583-1595. PubMed ID: 37278339
[TBL] [Abstract][Full Text] [Related]
9. Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial.
Kosaka H; Okamoto Y; Munesue T; Yamasue H; Inohara K; Fujioka T; Anme T; Orisaka M; Ishitobi M; Jung M; Fujisawa TX; Tanaka S; Arai S; Asano M; Saito DN; Sadato N; Tomoda A; Omori M; Sato M; Okazawa H; Higashida H; Wada Y
Transl Psychiatry; 2016 Aug; 6(8):e872. PubMed ID: 27552585
[TBL] [Abstract][Full Text] [Related]
10. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.
Sikich L; Kolevzon A; King BH; McDougle CJ; Sanders KB; Kim SJ; Spanos M; Chandrasekhar T; Trelles MDP; Rockhill CM; Palumbo ML; Witters Cundiff A; Montgomery A; Siper P; Minjarez M; Nowinski LA; Marler S; Shuffrey LC; Alderman C; Weissman J; Zappone B; Mullett JE; Crosson H; Hong N; Siecinski SK; Giamberardino SN; Luo S; She L; Bhapkar M; Dean R; Scheer A; Johnson JL; Gregory SG; Veenstra-VanderWeele J
N Engl J Med; 2021 Oct; 385(16):1462-1473. PubMed ID: 34644471
[TBL] [Abstract][Full Text] [Related]
11. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.
Guastella AJ; Einfeld SL; Gray KM; Rinehart NJ; Tonge BJ; Lambert TJ; Hickie IB
Biol Psychiatry; 2010 Apr; 67(7):692-4. PubMed ID: 19897177
[TBL] [Abstract][Full Text] [Related]
12. A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.
DeMayo MM; Song YJC; Hickie IB; Guastella AJ
Paediatr Drugs; 2017 Oct; 19(5):391-410. PubMed ID: 28721467
[TBL] [Abstract][Full Text] [Related]
13. Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial.
Dadds MR; MacDonald E; Cauchi A; Williams K; Levy F; Brennan J
J Autism Dev Disord; 2014 Mar; 44(3):521-31. PubMed ID: 23888359
[TBL] [Abstract][Full Text] [Related]
14. Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.
Parker KJ; Oztan O; Libove RA; Sumiyoshi RD; Jackson LP; Karhson DS; Summers JE; Hinman KE; Motonaga KS; Phillips JM; Carson DS; Garner JP; Hardan AY
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):8119-8124. PubMed ID: 28696286
[TBL] [Abstract][Full Text] [Related]
15. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.
Watanabe T; Kuroda M; Kuwabara H; Aoki Y; Iwashiro N; Tatsunobu N; Takao H; Nippashi Y; Kawakubo Y; Kunimatsu A; Kasai K; Yamasue H
Brain; 2015 Nov; 138(Pt 11):3400-12. PubMed ID: 26336909
[TBL] [Abstract][Full Text] [Related]
16. No side-effects of single intranasal oxytocin administration in middle childhood.
Verhees MWFT; Houben J; Ceulemans E; Bakermans-Kranenburg MJ; van IJzendoorn MH; Bosmans G
Psychopharmacology (Berl); 2018 Aug; 235(8):2471-2477. PubMed ID: 29915962
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid treatment for autism: a proof-of-concept randomized trial.
Aran A; Harel M; Cassuto H; Polyansky L; Schnapp A; Wattad N; Shmueli D; Golan D; Castellanos FX
Mol Autism; 2021 Feb; 12(1):6. PubMed ID: 33536055
[TBL] [Abstract][Full Text] [Related]
18. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
[TBL] [Abstract][Full Text] [Related]
19. At the Head and Heart of Oxytocin's Stress-Regulatory Neural and Cardiac Effects: A Chronic Administration RCT in Children with Autism.
Alaerts K; Daniels N; Moerkerke M; Evenepoel M; Tang T; Van der Donck S; Chubar V; Claes S; Steyaert J; Boets B; Prinsen J
Psychother Psychosom; 2023; 92(5):315-328. PubMed ID: 37820592
[TBL] [Abstract][Full Text] [Related]
20. Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms.
Kato Y; Kuwabara H; Okada T; Munesue T; Benner S; Kuroda M; Kojima M; Yassin W; Eriguchi Y; Kameno Y; Murayama C; Nishimura T; Tsuchiya K; Kasai K; Ozaki N; Kosaka H; Yamasue H
Mol Autism; 2021 Feb; 12(1):15. PubMed ID: 33622389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
